Discover trends, market shifts, and competitive outlooks for the anticoccidial drugs industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the Anticoccidial Drugs Market Growth Performance Trended Historically, And What Lies Ahead?3

The market size of anticoccidial drugs has seen robust growth in the past few years. It is projected to increase from $1.27 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The phenomenal growth in the past years was due to factors including a global rise in coccidiosis cases, heightened adoption of pets, widespread prevalence of coccidiosis, economic factors, and growing public concern over food safety and animal health.

The market for anticoccidial drugs is predicted to experience robust expansion in the coming years, reaching a valuation of $1.81 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 7.2%. Several factors contribute to this expected growth during the forecast period, including the expansion of veterinary care, the rising incidence of coccidiosis in animals, increased usage of synthetic drugs, escalating demand for feed additives, and growth in livestock production. Key trends anticipated for this forecast period include increased demand due to new strains of coccidiosis, a move towards natural and alternative treatments, innovation encouraged by intensified regulatory scrutiny, preferential consumer behavior towards antibiotic-free poultry products, advancements in drug delivery technology, amplified emphasis on preventative healthcare, and growth in applications within the aquaculture and pet industries.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Anticoccidial Drugs Market?

The escalating demand for meat proteins is set to fuel the expansion of the anticoccidial drug sector. Naturally found in animal flesh, meat proteins consist of a variety of amino acids crucial for numerous physiological functions. The increase in meat protein demand is due to factors such as population growth, increased disposable income, urbanization, and shifts in nutrition intake towards protein-laden foods. Anticoccidial medications are crucial instruments in contemporary livestock farming. These medicines aid in maintaining the animals’ wellbeing and productivity, ensuring that farmers can fulfill the mounting demand for meat proteins effectively and sustainably. For instance, a July 2023 report published by the France-based Organization for Economic Co-operation and Development (OECD) and the Italy-based Food and Agriculture Organization, indicated that even though there was an anticipated rise of 2% in average global meat demand per person from 2020-2022 to 2032, the FAO meat price index skyrocketed by 10% in 2022 due to a drop in export supplies. Therefore, the escalating demand for meat proteins is propelling the expansion of the anticoccidial drug sector. The increase in poultry farming is set to stimulate the growth of the anticoccidial drug sector. Poultry farming involves rearing tamed birds, such as chickens, turkeys, ducks, and geese, for meat, feather, and egg production. The boost in poultry farming is a result of augmenting demands for protein, advancements in farming approaches, and global trade expansion. Anticoccidial medications are often mixed into poultry feed or water as a preventative measure to safeguard the birds from coccidiosis, particularly during their early, most susceptible growth stages. For instance, in June 2023, according to the US-based USDA Economic Research Service, the total sales of the poultry industry crested to $76.9 billion in 2022, a substantial surge of 67% from the preceding year. Therefore, the boost in poultry farming propels the expansion of the anticoccidial drug sector.

Which Key Market Segments Comprise the Anticoccidial Drugs Market and Drive Its Revenue Growth?

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp

Which Areas Are Leading Regions in the Anticoccidial Drugs Market Expansion Across the Globe?

North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Anticoccidial Drugs Industry?

Leading firms in the anticoccidial drugs market are concentrating on the creation of ground-breaking solutions, including synthetic coccidiostat, to increase efficacy, reduce resistance progression, and meet the rising challenges in poultry and livestock management. Synthetic coccidiostat, a chemically created compound, is utilized to inhibit coccidiosis by restricting the growth and multiplication of coccidia parasites in animals. For instance, in March 2023, Zoetis, an animal health organization based in the US, introduced Avi-Deccox, a newly reformulated synthetic coccidiostat designed to keep coccidiosis in broiler chickens under control. This product is specifically aimed at the pathogens Eimeria acervulina and Eimeria tenella, which cause significant financial harm in poultry farming. The active ingredient in this product is decoquinate, just like its predecessor, Deccox. Avi-Deccox tackles the increasing problem of resistance associated with the repeated use of ionophores in poultry farming, employing a different approach to provide a more effective short-term elimination effect.

View the full report here:

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

How Is the Anticoccidial Drugs Market Conceptually Defined?

Anticoccidial drugs are a class of medications used to prevent and treat coccidiosis, a parasitic disease of the intestinal tract caused by protozoa of the genus Eimeria. These drugs work by inhibiting various stages of the coccidia life cycle, controlling the infection, and preventing the severe intestinal damage and related symptoms associated with the disease. Anticoccidial drugs are commonly used in veterinary medicine, particularly poultry, to enhance health and productivity by managing this widespread and economically significant condition.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.